MedPath

Seliforant

Generic Name
Seliforant
Drug Type
Small Molecule
Chemical Formula
C12H21N5
CAS Number
1164115-89-2
Unique Ingredient Identifier
B61N8R7TDH

Overview

Seliforant is under investigation in clinical trial NCT01260753 (Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge).

Background

Seliforant is under investigation in clinical trial NCT01260753 (Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 2
Completed
Posted: 2010/12/15
Sponsor:
Palau Pharma S.L.U.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath